DRG Epidemiology's coverage of SLE comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of SLE for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.

DRG Epidemiology's SLE forecast will answer the following questions:

  • How many people, regardless of diagnosis status, have SLE?
  • How does diagnosis status and drug-treated status differ within higher-income countries?
  • How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of SLE over the forecast period?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.

DRG Epidemiology provides at least ten years of forecast data for the following SLE patient populations:

  • Diagnosed incident SLE.
  • Diagnosed prevalent SLE.
  • Diagnosed prevalent SLE by renal involvement status.
  • Diagnosed prevalent SLE by drug-treatment status.

Note: Coverage may vary by country and region.

Table of contents

  • Epidemiology Dashboard
    • Introduction
      • Introduction
      • Systemic Lupus Erythematosus Epidemiology Dashboard

Author(s): Sunali D. Goonesekera, SM

Sunali Goonesekera is an Associate Epidemiologist at Decision Resources Group. Sunali holds a Master’s degree in Epidemiology from the Harvard School of Public Health and a in Biology (Honors) from Dartmouth College. Prior to joining Decision Resources Group, Sunali conducted epidemiological research and lead authored two manuscripts on racial/ethnic disparities in metabolic diseases at the New England Research Institutes. She has contributed to multiple publications in peer-reviewed journals in epidemiology and in the biological sciences.


Related Reports

Systemic Lupus Erythematosus | Landscape & Forecast | Disease Landscape & Forecast

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its cours...

View Details

Systemic Lupus Erythematosus | Unmet Need | Detailed, Expanded Analysis: Moderate to Severe Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect different organ systems of the body and manifest in a wide range...

View Details

Systemic Lupus Erythematosus | Disease Landscape and Forecast | G7 | 2019

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course,...

View Details

Systemic Lupus Erythematosus | Epidemiology | Extrapolated Worldwide Coverage

DRG’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key systemic lupus erythem...

View Details